MP Biomedicals Exhibits Diagnostics Kits and Sample Prep Solutions at MEDLAB Middle East 2021

MP Biomedicals (Irvine, CA, USA) exhibited its range of diagnostics kits and sample prep solutions at MEDLAB Middle East 2021.

At this year’s edition of MEDLAB Middle East 2021, the company presented the FastPrep family of homogenizers - a comprehensive laboratory solution that optimizes the lysis, grinding, or homogenization process from virtually any sample type. Mechanical lysis disrupts cells and tissues for the isolation of DNA, RNA, proteins, metabolites, and other small molecules, and eliminates the need for chemicals, enzymes, and detergents, which can inhibit some downstream processes. FastPrep instruments, Lysing Matrix tubes, and kits work together to deliver rapid, consistent, and efficient lysis and homogenization, resulting in high yields of purified nucleic acid or protein. A benchtop instrument utilizing bead-beating technology, the FastPrep provides complete and quantitative lysis of difficult and routine samples and is suitable in all applications that require grinding, lysing, or homogenization.


MP Biomedicals also showcased the AutoBlot System 36, an intelligent Western Blot processor that enables automated washing and incubation of up to 36 assay strips per run at pre-selected temperature. The AutoBlot System 36 helps to satisfy Immunoblot needs by minimizing human error, increasing productivity, and delivering accurate and consistent results.

Among its range of diagnostics kits, the company featured the Rapid SARS-CoV-2 Antigen Test Card which is a rapid, chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present on human nasal, nasopharyngeal or oropharyngeal swab specimens. Other products exhibited at the event included the Helico Blot 2.1 qualitative Western Blot Assay for the detection of IgG antibodies to H. pylori in human serum or plasma; ELISA and RIA new born screening panel for earlier diagnosis to confirm if a newborn requires essential medical intervention; HIV Blot 2.2 immunoblot for the in-vitro detection of antibodies to HIV in human serum or plasma samples; HTLV Blot 2.4 for the in-vitro detection of antibodies to HTLV-I and HTLV-II in human serum or plasma; HCV Blot 3.0 qualitative line blot immunoassay for the detection of antibodies to HCV; and the fully automated and integrated MPure-12 nucleic acid purification system to purify nucleic acids of the highest yield and purity for downstream applications.

Related Links:
MP Biomedicals